21ST CENTURY THERAPEUTICS, INC.

Address

440 BURROUGHS ST ROOM 447
DETROIT, MI, 48202

Information

DUNS: 968109702
# of Employees: 9

Ownership Information

Hubzone Owned: Y
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of a novel small molecule, UTL-5g, to treat oxaliplatin-induced throm

    Amount: $276,418.00

    DESCRIPTION (provided by applicant): Although oxaliplatin is a third-generation platinum drug, it has become the most prescribed amongst all platinum drugs overtaking its predecessors, cisplatin and c ...

    SBIRPhase I2013Department of Health and Human Services
  2. Novel small-molecule TNF-a modulators as chemoprotective agents

    Amount: $1,133,678.00

    DESCRIPTION (provided by applicant): Cisplatin is a widely used cytotoxic agent with therapeutic activity against various tumors, but also with substantial side effects, including nephrotoxicity, hepa ...

    SBIRPhase II2011Department of Health and Human Services
  3. TAS::75 0849::TAS

    Amount: $186,857.00

    Radiotherapy can potentially inflict serious damage on healthy normal organs. For example, pneumonitis and fibrosis are two well-recognized adverse effects from lung cancer radiotherapy: Currently, am ...

    SBIRPhase I2011Department of Health and Human Services
  4. Novel Small-molecule TNF-a Modulators as Chemoprotective Agents

    Amount: $154,852.00

    DESCRIPTION (provided by applicant): Cisplatin is a widely used cytotoxic agent with therapeutic activity against various tumors, but also with substantial side effects, including nephrotoxicity, hepa ...

    SBIRPhase I2009Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government